Payment overview · 2025
General Payments
$16.27
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael Scott Craig, MD
Allopathic & Osteopathic Physicians|Family Medicine · BRIGHTON, TN · NPI 1518951664
Verified facts
What the public records show
CMS Open Payments records show Michael Scott Craig, MD received $16.27 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 104 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $16.27 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $16.27 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $16.27 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 104 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
104 | 25 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 966 | 243 |
| Atorvastatin Calcium | Atorvastatin Calcium | 839 | 236 |
| Gabapentin | Gabapentin | 753 | 162 |
| Omeprazole | Omeprazole | 662 | 179 |
| Levothyroxine Sodium | Levothyroxine Sodium | 634 | 150 |
| Pantoprazole Sodium | Pantoprazole Sodium | 629 | 177 |
| Losartan Potassium | Losartan Potassium | 605 | 163 |
| Prednisone | Prednisone | 561 | 277 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 530 | 96 |
| Alprazolam | Alprazolam | 517 | 96 |
| Meloxicam | Meloxicam | 490 | 151 |
| Montelukast Sodium | Montelukast Sodium | 480 | 126 |
| Lisinopril | Lisinopril | 456 | 125 |
| Tamsulosin Hcl | Tamsulosin Hcl | 417 | 109 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 409 | 108 |
| Clopidogrel | Clopidogrel Bisulfate | 362 | 101 |
| Metoprolol Succinate | Metoprolol Succinate | 362 | 100 |
| Quetiapine Fumarate | Quetiapine Fumarate | 359 | 78 |
| Metformin Hcl | Metformin Hcl | 358 | 94 |
| Tizanidine Hcl | Tizanidine Hcl | 346 | 111 |
| Metformin Hcl Er | Metformin Hcl | 329 | 93 |
| Escitalopram Oxalate | Escitalopram Oxalate | 322 | 95 |
| Tramadol Hcl | Tramadol Hcl | 314 | 67 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 293 | 81 |
| Metoprolol Tartrate | Metoprolol Tartrate | 291 | 89 |
| Jardiance | Empagliflozin | 290 | 53 |
| Simvastatin | Simvastatin | 286 | 75 |
| Furosemide | Furosemide | 266 | 88 |
| Carvedilol | Carvedilol | 264 | 71 |
| Clonazepam | Clonazepam | 252 | 31 |
| Doxycycline Hyclate | Doxycycline Hyclate | 246 | 199 |
| Fluticasone Propionate | Fluticasone Propionate | 240 | 84 |
| Citalopram Hbr | Citalopram Hydrobromide | 238 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 238 | 66 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 235 | 41 |
| Bupropion Xl | Bupropion Hcl | 230 | 61 |
| Glimepiride | Glimepiride | 226 | 57 |
| Atenolol | Atenolol | 222 | 55 |
| Duloxetine Hcl | Duloxetine Hcl | 200 | 48 |
| Diclofenac Sodium | Diclofenac Sodium | 193 | 69 |
| Eliquis | Apixaban | 193 | 42 |
| Trazodone Hcl | Trazodone Hcl | 190 | 61 |
| Donepezil Hcl | Donepezil Hcl | 188 | 47 |
| Torsemide | Torsemide | 186 | 59 |
| Potassium Chloride | Potassium Chloride | 185 | 47 |
| Zolpidem Tartrate | Zolpidem Tartrate | 183 | 31 |
| Sertraline Hcl | Sertraline Hcl | 171 | 43 |
| Pioglitazone Hcl | Pioglitazone Hcl | 167 | 39 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 165 | 40 |
| Azelastine Hcl | Azelastine Hcl | 163 | 74 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 163 | 35 |
| Fluoxetine Hcl | Fluoxetine Hcl | 156 | 38 |
| Allopurinol | Allopurinol | 155 | 41 |
| Pregabalin | Pregabalin | 153 | 37 |
| Promethazine Hcl | Promethazine Hcl | 144 | 34 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 132 | 35 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 129 | 105 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 129 | 30 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 129 | 43 |
| Spironolactone | Spironolactone | 128 | 41 |
| Famotidine | Famotidine | 127 | 31 |
| Paroxetine Hcl | Paroxetine Hcl | 125 | 31 |
| Methylprednisolone | Methylprednisolone | 124 | 90 |
| Amitriptyline Hcl | Amitriptyline Hcl | 123 | 30 |
| Lorazepam | Lorazepam | 122 | 28 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 121 | 33 |
| Pravastatin Sodium | Pravastatin Sodium | 118 | 34 |
| Buspirone Hcl | Buspirone Hcl | 114 | 37 |
| Diazepam | Diazepam | 112 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 107 | 28 |
| Januvia | Sitagliptin Phosphate | 104 | 20 |
| Ozempic | Semaglutide | 104 | 25 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 103 | 31 |
| Clonidine Hcl | Clonidine Hcl | 101 | 33 |
| Finasteride | Finasteride | 101 | 34 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 96 | 75 |
| Meclizine Hcl | Meclizine Hcl | 96 | 37 |
| Amoxicillin | Amoxicillin | 93 | 72 |
| Hydralazine Hcl | Hydralazine Hcl | 92 | 27 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 92 | 20 |
| Ezetimibe | Ezetimibe | 89 | 23 |
| Ondansetron Hcl | Ondansetron Hcl | 86 | 31 |
| Minocycline Hcl | Minocycline Hcl | 85 | 77 |
| Trulicity | Dulaglutide | 85 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 84 | 20 |
| Memantine Hcl | Memantine Hcl | 83 | 17 |
| Xarelto | Rivaroxaban | 80 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 79 | 28 |
| Fluconazole | Fluconazole | 76 | 44 |
| Mirtazapine | Mirtazapine | 76 | 23 |
| Primidone | Primidone | 75 | 17 |
| Warfarin Sodium | Warfarin Sodium | 75 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 73 | 22 |
| Estradiol | Estradiol | 72 | 23 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 69 | 14 |
| Lansoprazole | Lansoprazole | 68 | 15 |
| Levetiracetam | Levetiracetam | 68 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 68 | 36 |
| Methocarbamol | Methocarbamol | 66 | 28 |
| Celecoxib | Celecoxib | 63 | 19 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 62 | 34 |
| Baclofen | Baclofen | 60 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 60 | 15 |
| Mounjaro | Tirzepatide | 60 | 15 |
| Carisoprodol | Carisoprodol | 59 | suppressed |
| Azithromycin | Azithromycin | 58 | 49 |
| Farxiga | Dapagliflozin Propanediol | 58 | 14 |
| Ramipril | Ramipril | 57 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 57 | 16 |
| Glipizide | Glipizide | 54 | suppressed |
| Lamotrigine | Lamotrigine | 53 | 18 |
| Levofloxacin | Levofloxacin | 53 | 39 |
| Alendronate Sodium | Alendronate Sodium | 52 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 52 | 18 |
| Nitroglycerin | Nitroglycerin | 52 | 28 |
| Synthroid | Levothyroxine Sodium | 52 | 15 |
| Topiramate | Topiramate | 52 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 51 | 14 |
| Ipratropium Bromide | Ipratropium Bromide | 50 | 12 |
| Digoxin | Digoxin | 49 | 11 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 49 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 48 | 13 |
| Symbicort | Budesonide/Formoterol Fumarate | 48 | suppressed |
| Glipizide Er | Glipizide | 46 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | 12 |
| Entresto | Sacubitril/Valsartan | 45 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 45 | suppressed |
| Naproxen | Naproxen | 44 | 11 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 43 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 43 | 12 |
| Lovastatin | Lovastatin | 43 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 42 | 13 |
| Valsartan | Valsartan | 42 | suppressed |
| Lactulose | Lactulose | 41 | 17 |
| Enalapril Maleate | Enalapril Maleate | 40 | 11 |
| Temazepam | Temazepam | 40 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 39 | 19 |
| Dicyclomine Hcl | Dicyclomine Hcl | 39 | 16 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 38 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 38 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 35 | 12 |
| Nystatin | Nystatin | 35 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 35 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 35 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 34 | suppressed |
| Premarin | Estrogens, Conjugated | 34 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 33 | suppressed |
| Constulose | Lactulose | 32 | 12 |
| Divalproex Sodium | Divalproex Sodium | 32 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 31 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | 11 |
| Nortriptyline Hcl | Nortriptyline Hcl | 30 | 14 |
| Mupirocin | Mupirocin | 29 | 26 |
| Testosterone Cypionate | Testosterone Cypionate | 29 | suppressed |
| Nifedipine Er | Nifedipine | 28 | suppressed |
| Ibuprofen | Ibuprofen | 27 | 11 |
| Ondansetron Odt | Ondansetron | 27 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 26 | suppressed |
| Ranolazine Er | Ranolazine | 26 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | 13 |
| Acyclovir | Acyclovir | 25 | 14 |
| Fenofibrate | Fenofibrate | 25 | suppressed |
| Metolazone | Metolazone | 25 | 11 |
| Terbinafine Hcl | Terbinafine Hcl | 25 | 11 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 25 | suppressed |
| Carbamazepine | Carbamazepine | 24 | suppressed |
| Metronidazole | Metronidazole | 24 | 15 |
| Solifenacin Succinate | Solifenacin Succinate | 24 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 23 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 23 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 23 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 22 | 17 |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | 11 |
| Dutasteride | Dutasteride | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Risperidone | Risperidone | 20 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 19 | 17 |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Eszopiclone | Eszopiclone | 19 | suppressed |
| Folic Acid | Folic Acid | 19 | suppressed |
| Loperamide | Loperamide Hcl | 19 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 17 | suppressed |
| Probenecid | Probenecid | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Bumetanide | Bumetanide | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | 12 |
| Levemir Flexpen | Insulin Detemir | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 16 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 15 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 15 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 15 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 14 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 14 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 12 |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 12 | suppressed |
| Cabergoline | Cabergoline | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Lyrica | Pregabalin | 12 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Diflunisal | Diflunisal | 11 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.27 · 1 records | Novo Nordisk Inc | Ozempic | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error